Fortress Biotech, Inc.
NASDAQ: FBIO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Lindsay Allan Rosenwald
- Employees
- 101
- Headquarters
- Bay Harbor Islands, United States
- IPO year
- 2011
- Market cap
- $104.3M
- Website
- https://www.fortressbiotech.com
Loading FBIO…
Loading profile data…Frequently asked questions about FBIO
What does Fortress Biotech, Inc. (FBIO) do?
Fortress Biotech, Inc. operates as a biopharmaceutical firm dedicated to the development and commercialization of a diverse range of pharmaceutical and biotechnology products. The company currently offers a portfolio of dermatological treatments. These include Ximino and Targadox, both formulated to address various forms of acne (ranging from mo...
Where does FBIO trade?
Fortress Biotech, Inc. (FBIO) trades on the NASDAQ Capital Market.
What sector is FBIO in?
Fortress Biotech, Inc. (FBIO) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Fortress Biotech, Inc.?
Lindsay Allan Rosenwald is the chief executive officer of Fortress Biotech, Inc. (FBIO).
Where is Fortress Biotech, Inc. headquartered?
Fortress Biotech, Inc. is headquartered in United States.
Does FBIO pay a dividend?
Fortress Biotech, Inc. (FBIO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did FBIO go public?
Fortress Biotech, Inc. (FBIO) completed its initial public offering in 2011.